A Placebo-controlled, Double-blind Study of Mesoglycan in the Treatment of Chronic Venous Ulcers-Reference-Cited by-同舟云学术

A Placebo-controlled, Double-blind Study of Mesoglycan in the Treatment of Chronic Venous Ulcers

Published:2001-10 Issue:4 Volume:22 Page:365-372
ISSN:1078-5884
Container-title:European Journal of Vascular and Endovascular Surgery
language:en
Short-container-title:European Journal of Vascular and Endovascular Surgery

Author:

Arosio E.,Ferrari G.,Santoro L.,Gianese F.,Coccheri S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Surgery

Reference32 articles.

1. Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force;Kurz;Int Angiol,1999

2. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways;Ofosu;Blood,1984

3. Insight into the mechanism of action of heparin cofactor II;Tollefsen;Thromb Haemost,1995

4. Therapeutic uses of heparin beyond its traditional role as an anticoagulant;Tyrrell;Trends Pharmacol Sci,1995

5. Effects of unfractionated heparin, dermatan sulfate and low molecular weight heparin on vessel wall permeability in rabbits;Blajchman;Ann NY Acad Sci,1989

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sulodexide Inhibits Arterial Contraction via the Endothelium-Dependent Nitric Oxide Pathway;Journal of Clinical Medicine;2024-04-17

2. Clinical evidence and rationale of mesoglycan to treat chronic venous disease and hemorrhoidal disease: a narrative review;Updates in Surgery;2024-02-14

3. Bioinductive Dressing;Pearls and Pitfalls in Skin Ulcer Management;2023

4. A Call to Action by the Italian Mesotherapy Society on Scientific Research;Drug Design, Development and Therapy;2021-07

5. What is the role of pharmacological therapy in venous ulcers management?;Minerva Cardiology and Angiology;2021-04